These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32345623)

  • 1. Overcoming hypoxia-induced functional suppression of NK cells.
    Solocinski K; Padget MR; Fabian KP; Wolfson B; Cecchi F; Hembrough T; Benz SC; Rabizadeh S; Soon-Shiong P; Schlom J; Hodge JW
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32345623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody.
    Jochems C; Hodge JW; Fantini M; Tsang KY; Vandeveer AJ; Gulley JL; Schlom J
    Int J Cancer; 2017 Aug; 141(3):583-593. PubMed ID: 28477372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations.
    Fabian KP; Padget MR; Donahue RN; Solocinski K; Robbins Y; Allen CT; Lee JH; Rabizadeh S; Soon-Shiong P; Schlom J; Hodge JW
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32439799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele.
    Jochems C; Hodge JW; Fantini M; Fujii R; Morillon YM; Greiner JW; Padget MR; Tritsch SR; Tsang KY; Campbell KS; Klingemann H; Boissel L; Rabizadeh S; Soon-Shiong P; Schlom J
    Oncotarget; 2016 Dec; 7(52):86359-86373. PubMed ID: 27861156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity employing NK or high-affinity NK cells in combination with cetuximab.
    Fujii R; Schlom J; Hodge JW
    J Neurosurg; 2018 May; 128(5):1419-1427. PubMed ID: 28753113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct and antibody-dependent cell-mediated cytotoxicity of head and neck squamous cell carcinoma cells by high-affinity natural killer cells.
    Friedman J; Padget M; Lee J; Schlom J; Hodge J; Allen C
    Oral Oncol; 2019 Mar; 90():38-44. PubMed ID: 30846174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy utilizing the combination of natural killer- and antibody dependent cellular cytotoxicity (ADCC)-mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition.
    Fenerty KE; Padget M; Wolfson B; Gameiro SR; Su Z; Lee JH; Rabizadeh S; Soon-Shiong P; Hodge JW
    J Immunother Cancer; 2018 Nov; 6(1):133. PubMed ID: 30486888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK.
    Giles AJ; Hao S; Padget M; Song H; Zhang W; Lynes J; Sanchez V; Liu Y; Jung J; Cao X; Fujii R; Jensen R; Gillespie D; Schlom J; Gilbert MR; Nduom EK; Yang C; Lee JH; Soon-Shiong P; Hodge JW; Park DM
    JCI Insight; 2019 Oct; 4(20):. PubMed ID: 31536478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanized anti-CD123 antibody facilitates NK cell antibody-dependent cell-mediated cytotoxicity (ADCC) of Hodgkin lymphoma targets via ARF6/PLD-1.
    Ernst D; Williams BA; Wang XH; Yoon N; Kim KP; Chiu J; Luo ZJ; Hermans KG; Krueger J; Keating A
    Blood Cancer J; 2019 Jan; 9(2):6. PubMed ID: 30647406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies.
    Friedman J; Morisada M; Sun L; Moore EC; Padget M; Hodge JW; Schlom J; Gameiro SR; Allen CT
    J Immunother Cancer; 2018 Jun; 6(1):59. PubMed ID: 29925431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC.
    Balsamo M; Manzini C; Pietra G; Raggi F; Blengio F; Mingari MC; Varesio L; Moretta L; Bosco MC; Vitale M
    Eur J Immunol; 2013 Oct; 43(10):2756-64. PubMed ID: 23913266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Exercise Increases NK Cell Mitochondrial Respiration and Cytotoxicity against Triple-Negative Breast Cancer Cells under Hypoxic Conditions.
    Cho E; Stampley J; Wall R; Matthews R; Zunica E; Brown JC; Johannsen NM; Irving BA; Spielmann G
    Med Sci Sports Exerc; 2023 Dec; 55(12):2132-2142. PubMed ID: 37436930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia.
    Xu LJ; Ma Q; Zhu J; Li J; Xue BX; Gao J; Sun CY; Zang YC; Zhou YB; Yang DR; Shan YX
    Mol Med Rep; 2018 Jun; 17(6):8111-8120. PubMed ID: 29693186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines.
    Roda JM; Joshi T; Butchar JP; McAlees JW; Lehman A; Tridandapani S; Carson WE
    Clin Cancer Res; 2007 Nov; 13(21):6419-28. PubMed ID: 17962339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor.
    Kaur K; Safaie T; Ko MW; Wang Y; Jewett A
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33440654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Selective Degradation of Synaptic Connexin 43 Protein by Hypoxia-induced Autophagy Impairs Natural Killer Cell-mediated Tumor Cell Killing.
    Tittarelli A; Janji B; Van Moer K; Noman MZ; Chouaib S
    J Biol Chem; 2015 Sep; 290(39):23670-9. PubMed ID: 26221040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short Term Hypoxia Synergizes with Interleukin 15 Priming in Driving Glycolytic Gene Transcription and Supports Human Natural Killer Cell Activities.
    Velásquez SY; Killian D; Schulte J; Sticht C; Thiel M; Lindner HA
    J Biol Chem; 2016 Jun; 291(25):12960-77. PubMed ID: 27129235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
    Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
    J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma.
    Pahl JH; Ruslan SE; Buddingh EP; Santos SJ; Szuhai K; Serra M; Gelderblom H; Hogendoorn PC; Egeler RM; Schilham MW; Lankester AC
    Clin Cancer Res; 2012 Jan; 18(2):432-41. PubMed ID: 22090361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia impairs anti-viral activity of natural killer (NK) cells but has little effect on anti-fibrotic NK cell functions in hepatitis C virus infection.
    Wolter F; Glässner A; Krämer B; Kokordelis P; Finnemann C; Kaczmarek DJ; Goeser F; Lutz P; Nischalke HD; Strassburg CP; Spengler U; Nattermann J
    J Hepatol; 2015 Dec; 63(6):1334-44. PubMed ID: 26297916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.